Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

Clinical trial NCT05025605 · RECRUITING

Trial details

NCT number: NCT05025605
Sponsor: BioXcel Therapeutics Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Schizo-Affective Disorder Schizophreniform; Schizophrenic Bipolar Disorder I Bipolar Disorder II

Start date: 2021-08-27
Primary completion: 2027-07-31
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.